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Edited by Gerrit van MeerAbstract The maintenance of transbilayer distribution of phos-
pholipids is crucial for proper cell function. Intramembrane
transport of lipids is mediated by three activities termed ﬂopp-
ases, ﬂippases, and scramblases. Members of the ATP-binding
cassette transporter family and P-type ATPase superfamily have
been implicated in the translocation of lipids. The importance of
these activities is exempliﬁed by several severe human inherited
disorders that are caused by defects in intramembranous trans-
port of lipids. In order to elucidate the molecular mechanisms
that underlie these disorders, the combination of in vivo, bio-
chemical, and structural analyses on intramembrane transporters
is crucial.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Biological membranes are bilayers composed of a broad
range of glycerolipid- and sphingolipid species. One of the fas-
cinating structural features of biological membranes in animal
cells is the asymmetric distribution of speciﬁc phospholipids
over the exoplasmic- and cytoplasmic leaﬂet of the bilayer
[1,2]. Plasma membranes display high asymmetry while mem-
branes of the endoplasmic reticulum (ER) are less asymmetric
(reviewed in [1]). For mitochondria and peroxisomal mem-
branes the distribution is at present not clear. In the early
70-ties, Bretscher [3] and Gordesky and Marinetti [4] used
chemical probes to demonstrate that the aminophospholipids
phosphatidylserine (PS) and phosphatidylethanolamine (PE)
are concentrated in the cytoplasmic leaﬂet of the erythrocyte
bilayer. Verkleij and coworkers [5] studied the sensitivity of
erythrocyte membranes to phospholipase A2- and sphingomy-
elinase, and showed that phosphatidylcholine (PC) was equally
distributed over both leaﬂets, whereas sphingomyelin (SM) al-
most exclusively localized to the exoplasmic leaﬂet (Fig. 1).
The major fraction (i.e. 80%) of the less abundant phospholip-
ids, like phosphatidylinositol (PI), PI derivatives, and phos-
phatidic acid are conﬁned to the cytoplasmic leaﬂet [6–8].
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[9]. Thus far, the transbilayer distribution of cholesterol re-
mains unclear. Some studies in erythrocytes describe a sym-
metric distribution of cholesterol [10,11], whereas others
reported a preferential presence in the cytoplasmic leaﬂet of
erythrocytes and synaptic plasma membranes [12,13]. Alterna-
tively, one may argue that cholesterol is enriched in the exo-
plasmic leaﬂet due to its high aﬃnity for SM [14]. The
phospholipid distribution in polarized epithelial cells is some-
what diﬀerent from non-polarized erythrocytes. For instance,
the predominant lipid species in the exoplasmic leaﬂet of the
hepatocyte apical (canalicular) and sinusoidal membranes are
PC, SM, and cholesterol, while the composition of the lateral
membrane resembles that of the erythrocyte membrane
[15–17].
Phospholipid randomization, e.g. PS exposure in the exo-
plasmic leaﬂet, is associated with many (patho)physiological
processes, including platelet activation, sperm capacitation,
and other membrane fusion events, including phagocytic rec-
ognition and clearance of apoptotic cells [18–21]. In addi-
tion, phospholipid randomization can aﬀect structure and
activity of channels, transporters, and signal transducing
proteins possibly by disturbing the lipid shell of these mem-
brane proteins [22]. Thus, maintenance of transbilayer
phospholipid asymmetry is of vital importance for normal
cell function.
Phospholipids tend to equilibrate between the two leaﬂets of
bilayers (scrambling), a process that disturbs transbilayer
asymmetry. Generally, this process is very slow and depends
on lipid headgroup structure and polarity, hydrophobicity of
the acyl chains, and lipid packing in the bilayer [23]. In living
cells, however, scrambling is accelerated by fusion and pinch-
ing of vesicles to and from membranes. Therefore, the asym-
metric transbilayer distribution of phospholipids must be
actively maintained by proteins that translocate phospholipids
in the bilayer. Three classes of proteins are involved in regulat-
ing phospholipid distribution in membrane bilayers, i.e. lipid
ﬂoppases, lipid ﬂippases, and scramblases [24,25] (Fig. 2).
Lipid ﬂoppases and ﬂippases are ATP-dependent activities that
maintain transbilayer distribution of phospholipids by translo-
cating speciﬁc phospholipid species from the cytoplasmic to
the exoplasmic leaﬂet of the bilayer and vice versa, respec-
tively. Scramblases are Ca2+-dependent, bidirectional activities
that, upon activation, dissipate phospholipid asymmetry. In
apoptotic cells, however, scramblase activity is activated via
a distinct pathway rather than elevation of intracellular cal-
cium [26].blished by Elsevier B.V. All rights reserved.
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Fig. 1. Transbilayer distribution of the most prominent phospholipid
species in the erythrocyte bilayer (Figure adapted and modiﬁed from
Verkleij and coworkers [142]). SM, sphingomyelin; PC, phosphatidyl-
choline; PE, phosphatidylethanolamine; PS, phosphatidylserine; PI,
phosphatidylinositol and derivatives of PI.
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Members of the ATP-binding cassette (ABC) transporter
superfamily are integral membrane proteins that mediate the
ATP-dependent transport of a wide variety of compounds
across biological membranes, including xenobiotics, lipids,
peptides, ions, and amino acids. Although ABC transporters
were initially characterized as mediators of multidrug resistance
in tumor cells, important physiological functions for many of
these proteins have now been described [27]. ABC transporters
have also been implicated in the translocation of lipids from the
cytoplasmic- to the exoplasmic/luminal leaﬂet of bilayers
[25,28], amongst which are (ﬂuorescent analogs of) PC, short-
chain analogs of PC, glucosylceramide, platelet-activating fac-
tor, ﬂuorescent analogs of PS and SM, and cholesterol. In the
human genome 48 ABC transporters have been identiﬁed that
are categorized into seven subfamilies, ABCA–ABCG [29].
Thus far, 18 ABC transporters have been implicated in human
inherited disorders, of which eight represent disorders associ-
ated with intramembranous lipid transport.
1.2. Lipid ﬂippases
The ﬁrst lipid ﬂippase activity was described in 1984 in
erythrocyte membranes [30], an aminophospholipid (analog)-
speciﬁc ATPase activity that was reconstituted a few years
later [31]. Subsequent identiﬁcation and cloning of a chroma-
ﬃn granular ﬂippase activity resulted in the identiﬁcation of
a new branch in the phylogenetic tree of the P-type ATPaseFloppase F
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Fig. 2. Highly schematic representation of a membrane bilayer in which thre
the outward translocation (ﬂopping), inward translocation (ﬂipping), and scsuperfamily, the type 4 subfamily [32,33]. Type 4 ATPases
are deviant from the other subfamilies in that they have been
implicated in the translocation of phospholipids, rather than
being pumps for cations. In the yeast Saccharomyces cerevi-
siae, type 4 ATPases mediate the translocation of both
NBD-labeled- and natural glycerophospholipids [34,35]. In
yeast, these activities are indispensable for intracellular mem-
brane and protein traﬃcking, ﬂuid-phase and receptor-medi-
ated endocytosis, processes that require lipid ﬂipping to
initiate budding or fusion of membrane vesicles from or with
other membranes. In humans, 14 type 4 ATPase genes have
been identiﬁed, all having orthologs in the mouse [36,37]. Thus
far, only 1 human disorder has been identiﬁed as being caused
by a deﬁcient type 4 ATPase.
1.3. Scramblases
Collapse of membrane asymmetry was ﬁrst observed in acti-
vated blood platelets which exposed PS [38]. Activation of
blood platelets by elevation of intracellular [Ca2+], induced
scramblase activity and inhibited lipid ﬂippase activity [39].
Normalization of intracellular Ca2+ coincided with enhanced
lipid ﬂippase and reduced scramblase activities and a restora-
tion of phospholipid asymmetry. Lipid scrambling is bidirec-
tional and aspeciﬁc for the lipid headgroup, but dependent
on headgroup size [40,41]. Scramblase activities have also been
identiﬁed in plasma membranes of other cell types and in mem-
branes of the endoplasmic reticulum and the Golgi apparatus
[42,43]. Fractionation and reconstitution of blood platelet and
erythrocyte membrane proteins indicated the presence of one
or more proteins involved in phospholipid scrambling, includ-
ing a 37-kDa candidate scramblase from erythrocytes (termed
phospholipid scramblase 1 [PLSCR1]) [44]. PLSCR1 cDNA
has been cloned and recombinant expression of the protein
coincided with translocation of membrane phospholipids
[45]. Recently, three homologs of PLSCR1 have been isolated
[46]. PLSCR1 is probably not the erythrocyte-speciﬁc scramb-
lase, since Plscr1/ mice do not display impaired erythrocyte
scramblase activity [47]. Alternatively, recombinant PLSCR1
has been implicated in caspase-dependent PS exposure in the
plasma membrane of CHO cells as part of the apoptotic re-
sponse [48]. The molecular characteristics of other members
of the PLSCR protein family, as well as their role in phospho-
lipid scrambling, remain to be demonstrated.lippase
mine
phosphatidylcholine
sphingolipid
Scramblase
ATP Ca2+
e diﬀerent phospholipid translocases have been indicated implicated in
rambling (ﬂip-ﬂop) of phospholipids.
Table 1
Human disorders caused by defects in transport proteins implicated in intramembranous transport of lipids
Gene Disease Putative substrate(s)
ABCA1 Tangier disease PC, cholesterol
ABCA3 Respiratory distress syndrome PC
ABCA4 Retinal degenerative disorders all-trans retinal, N-retinylidene-PE, PE
ABCA12 Keratinization disorders Glucosylceramide
ABCB4 Progressive familial cholestasis type 3 PC
ABCD1 X-linked adrenoleukodystrophy Very long-chain fatty acids
ABCG5 Sitosterolemia Plant sterols, cholesterol
ABCG8
ATP8B1 Progressive familial intrahepatic cholestasis type 1 PS
Not known Scott syndrome Glycerophospholipids
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mechanisms underlying human inherited disorders that are
caused by defects in intramembranous transport of lipids
(Table 1). Thus far, eight disorders have been described caused
by defective ATP-binding cassette (ABC) transporter proteins
and one disorder by a defective P-type ATPases. One disorder
is associated with a defective scramblase activity of which the
genetic origin is presently unknown. Below we will give a brief
survey of these disorders.2. Disorders caused by ABC transporter deﬁciencies
2.1. The ABCA subfamily
The human ABCA subfamily contains 12 members [49]. Five
ABCA transporters, ABCA5, 6, 8, 9, and 10, are clustered on
chromosome 17, and form a subclass in this subfamily. Many
ABCA transporters are implicated in the transport of choles-
terol and phospholipids and some are transcriptionally regu-
lated by cholesterol. At present, four members have been
linked to severe human disorders caused by defects in intra-
membranous transport of lipids.
2.1.1. ABCA1 – Tangier disease. Tangier disease (TD) is a
rare autosomal recessive disorder caused by mutations in
ABCA1 [50–53]. ABCA1 is a plasma membrane protein that
is ubiquitously expressed with high expression in liver, small
intestine, adrenal gland, lung, placenta, and fetal tissues. Ini-
tially it was hypothesized that ABCA1 was required for engulf-
ment of apoptotic bodies during programmed cell death [54].
Hamon and colleagues subsequently showed that ABCA1
overexpression in HeLa cells resulted in enhanced engulfment
of apoptotic thymocytes [55]. In addition, the authors showed
Ca2+ ionophore-induced PS exposure in wild-type red blood
cell membranes, which was impaired in red blood cells from
Abca1/ mice. However, identiﬁcation of mutations in
ABCA1 in TD patients rendered a role for ABCA1 in lipopro-
tein metabolism more likely. TD is biochemically characterized
by extremely low serum high density lipoprotein cholesterol
(HDL-c) levels and apolipoprotein A-I (apoA-I). Further-
more, TD patients accumulate high concentrations of choleste-
ryl esters in macrophages and various tissues, including liver,
intestine, tonsils, spleen, lymph nodes, and neuronal Schwann
cells [56,57]. As a consequence, TD patients have increased risk
to develop cardiovascular disease. HDL is considered an essen-
tial determinant of reverse cholesterol transport, i.e. the path-
way from the periphery to the liver via which excess body
cholesterol is eliminated [58]. ApoA-I is the major acceptor
of phospholipid and cholesterol and essential in the initiationof HDL formation. In the 90-ties, several groups showed that
ﬁbroblasts from TD patients are impaired in the eﬄux of cho-
lesterol and phospholipids to apoA-I, and these cells displayed
reduced interaction of apoA-I with high-aﬃnity binding sites
[59–61]. Subsequent studies demonstrated a relation between
ABCA1 expression and cholesterol eﬄux to apoA-I [55,62].
Cholesterol eﬄux depended on a physical interaction between
apoA-I and ABCA1 [63,64]. Similarly, ABCA1 could mediate
the translocation of PC and SM to apoA-I as an acceptor
[55,59,65]. These data strongly suggest a role for ABCA1 in
the translocation of cholesterol and choline-containing phos-
pholipids. The current concept is that ABCA1 primarily ﬂops
PC to lipid-free ApoA-I as an acceptor, which renders the nas-
cent HDL particle a better acceptor for cholesterol. The ﬂop-
pase ABCG1 would subsequently translocate cholesterol to
this acceptor [66]. However, the preferred endogenous lipid
substrates for ABCA1 and ABCG1 remain to be identiﬁed.
Recently it was demonstrated that apoA-I binding to ABCA1
activates a signal transduction pathway, in which subsequent
binding of a small G-protein to ABCA1 is essential for eﬄux
of cholesterol to apoA-I [67]. These studies indicate that
ABCA1 may both be a lipid ﬂoppase and a receptor for
apoA-I.
2.1.2. ABCA3 – respiratory distress syndrome. Respiratory
distress syndrome (RDS) is a severe autosomal recessive disor-
der caused by mutations in ABCA3 [68]. RDS presents in neo-
nates with severe respiratory failure, surfactant deﬁciency,
lipid and protein accumulation in the airspaces, and accumula-
tion of macrophages [69]. RDS patients either die within a few
months after birth or develop chronic lung disease depending
on the nature of the mutation [68]. ABCA3 is highly expressed
in alveolar type II cells of the lung where it localizes to the lim-
iting membrane of lamellar bodies [70]. Lamellar bodies are
compartments in which pulmonary surfactant is assembled
and stored [71]. Pulmonary surfactant is a complex mixture
that consists of predominantly dipalmitoylPC (DPPC)
(80%), and small amounts of cholesterol (10%), triglycer-
ides, free fatty acids, and protein (10%) [72]. The surfactant
is exocytosed from lamellar bodies into the air space where it
coats the water ﬁlm on the alveolar epithelium. This is essential
for proper respiratory function as the surfactant lowers the
surface tension of the epithelium and thus prevents collapse
of the alveoli during gas exchange. Electron microscopic anal-
yses of RDS lung tissue indicates that the lamellar bodies are
smaller and contain dense peripheral inclusions. ABCA3 may
be a ﬂoppase for DPPC, extruding phospholipid into the
lamellar bodies that are subsequently exocytosed into the air-
space. Recently, Cheong and colleagues [73] showed that over-
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the generation of lamellar body-like structures that expressed
ABCA3 and accumulated lipid. In addition, the authors
showed a clear relation between GFP-tagged ABCA3 expres-
sion and uptake of NBD-labeled lipid probes into these vesi-
cles, including NBD-PC, NBD-cholesterol, and NBD-SM,
but not of NBD-PE.
2.1.3. ABCA4 – retinal degenerative disorders. Mutations
in ABCA4 cause four phenotypically related autosomal reces-
sive visual degenerative disorders, including Stargardt disease
(STGD), cone-rod dystrophy (CORD), fundus ﬂavimaculatus
(FFM), and retinitis pigmentosa (RP) [74–77]. Due to the
high allelic heterogeneity in ABCA4 (over 400 genetic varia-
tions have been reported), it is diﬃcult to identify the disease
causing mutations. In general, the severe phenotype of RP is
caused by homozygous null mutations, whereas CORD (null/
moderate missense mutation) and STGD and FFM (null/mild
missense, moderate/moderate missense) are caused by hetero-
zygous mutations resulting in less severe phenotypes. In addi-
tion, age-related macular degeneration (AMD), i.e. visual loss
frequently observed in elderly, is associated with genetic vari-
ation in ABCA4 [78,79]. ABCA4-associated disorders are
characterized by loss of central vision and a delayed recovery
of dark adaptation after light exposure. In these patients as
well as in Abca4/ mice, the retinal pigment epithelium
(RPE) accumulates large quantities of lipofuscin [80,81].
ABCA4 localizes along the rims and incisures of the disc
membranes in the outer segment of the photoreceptor of the
eye (which underlies the RPE) [82–84]. Photoactivated rho-
dopsin, which is present in the disc membranes of the outer
segment, is converted to all-trans retinal and a derivative here-
of, N-retinylidene-phosphatidylethanolamine (PE). ABCA4
would be involved in the ﬂopping of all-trans retinal and/or
N-retinylidene-PE from the luminal leaﬂet to the cytosolic
leaﬂet of the disc membrane [81]. Subsequent conversion of
these substrates to all-trans retinol, transfer to the RPE, oxi-
dation to 11-cis retinal, transfer to the outer segment, and
conversion with opsin to form rhodopsin completes the visual
cycle. Abca4/ mice and ABCA4-deﬁcient humans accumu-
late all-trans retinal, N-retinylidene-PE, and PE in the disc
membranes of the outer segment of the photoreceptor
[80,81]. The accumulated all-trans retinal is a precursor of
the toxic A2E. Subsequent deposition of A2E in the RPE
causes photoreceptor degeneration and causes loss of vision
[85]. Puriﬁcation and reconstitution of ABCA4 indicated that
ABCA4 ATPase activity is stimulated by all-trans retinal, 11-
cis-retinal, and N-retinylidene-PE [86,87]. In addition, reti-
noid-induced stimulation of ATPase activity depended on
the presence of PE in the reconstituted system. Recently, it
was shown that ABCA4 preferentially bound N-retinylidene-
PE [88]; the authors suggested N-retinylidene-PE to be the
preferred substrate for ABCA4.
2.1.4. ABCA12 – keratinization disorders. Genetic defects
in ABCA12 are the cause of two severe, rare, autosomal reces-
sive skin disorders i.e. Harlequin ichthyosis (HI) and lamellar
ichthyosis type 2 (LI2) [89–91]. Patients are characterized by a
marked thickening of the outer layer of the epidermis, the stra-
tum corneum which contains the keratinocytes. Patients with
the severe type, HI, usually die within a few days after birth
due to dehydration, respiratory stress, or severe infection. Epi-
dermal keratinocytes form the ﬁrst line of defense to external
stimuli and prevent ﬂuid loss by formation of a semi-perme-able and ﬂexible barrier [92]. To accomplish this, keratinocytes
are embedded in intercellular lipid lamellae, a liquid-ordered
lipid phase composed of cholesterol, non-branched, saturated
ceramides, and free fatty acids [93]. These lipid lamellae are
assembled and stored in lamellar granules, small organelles
that originate from the trans-Golgi network (TGN), and are
exocytosed from granular cells. The major lipid species in
lamellar granules are glucosylceramides with also some phos-
pholipids and cholesterol [92,94]. These lamellar granules are
absent or abnormal in HI or LI2 which results in absence of
intercellular lipid lamellae [95,96]. Akiyama and colleagues
[97] demonstrated that ABCA12-positive lamellar granules
localize close to, and fuse with the keratinocyte plasma mem-
brane. Furthermore, using ﬁbroblasts from HI patients, they
showed an altered glucosylceramide distribution throughout
these cells compared to control cells. Corrective ABCA12
expression in HI ﬁbroblasts restored glucosylceramide distri-
bution which colocalized with ABCA12. Although the sub-
strate for ABCA12 remains elusive, one may hypothesize
that ABCA12 translocates glucosylceramide. This process
may take place in the membranes of TGN-derived lamellar
granules, at the plasma membrane, or in both membranes.
2.2. The ABCB subfamily
The human ABCB subfamily constitutes 4 full transporters,
i.e. ABCB1, 4, 5, and 11, as well as seven half transporters [29].
Thus far, two ABCB transporters have been associated with a
human disorder, i.e. ABCB4 and ABCB11. Deﬁciency of both
transporters gives rise to severe, inherited liver diseases caused
by impaired bile formation [98]. Bile formation is essential
elimination of lipophilic endo- and xenobiotics, for intestinal
solubilization and absorption of dietary lipids and fat-soluble
vitamins, and for the regulation of cholesterol homeostasis.
Primary bile is formed in bile canaliculi, tubular spaces bor-
dered by the apical (canalicular) membranes of adjacent hepa-
tocytes. A major driving force for bile formation is the
excretion of bile salts, which results in a steep osmotic gradient
and subsequent water ﬂow into the bile canalicular lumen. Bile
salts are excreted by the bile salt export pump, ABCB11 [99].
Bile salts have detergent properties that enable them to solubi-
lize membrane lipids and are present in millimolar concentra-
tions in the canalicular lumen. However, in the canaliculus, the
detergent action of bile salts is decreased by molecular associ-
ation with PC [100]. PC is extracted by biliary bile salts after
outward translocation across the canalicular membrane by
the ﬂoppase ABCB4 [101]. Both ABCB4 and ABCB11 are
exclusively expressed in the canalicular membrane of hepato-
cytes although a recent study reported expression of both
ABC transporters in kidney of mice [102]; the signiﬁcance of
this ﬁnding remains to be determined.
2.2.1. ABCB4 – progressive familial intrahepatic cholestasis
type 3 (PFIC3). Mutations in ABCB4 are the cause of
PFIC3, a very rare autosomal recessive liver disorder charac-
terized by progressive liver disease [103–105]. Patients present
in infancy with liver ﬁbrosis (progressing into cirrhosis), portal
inﬂammation, and strong bile duct proliferation. 50% of the
patients need to undergo a liver transplantation. Sparse data
on bile composition of PFIC3 patients demonstrate strongly
reduced biliary PC concentrations [106]. The combined eﬀect
of normal bile salt output and impaired PC translocation
causes damage to the membranes. ABCB4 deﬁciency is
also associated with primary biliary cirrhosis, intrahepatic
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nancy [101]. The major phospholipid in bile of mice is PC.
Abcb4/ mice have no detectable amounts of both PC and
cholesterol in bile, whereas wild-type mice excrete considerable
amounts [107]. Transgenic expression of ABCB4 in Abcb4/
mice completely rescued the phenotype [108]. These data indi-
cated that ABCB4 is a ﬂoppase for PC. Despite the physiolog-
ical function of ABCB4, the molecular mechanisms underlying
this activity have not been extensively studied. ABCB4 overex-
pression in polarized cells resulted in a speciﬁc outward trans-
location of NBD-PC [109]. Thus far, only one study has
demonstrated ABCB4-mediated translocation of natural PC
by metabolic labeling of ﬁbroblasts with labeled choline
[110]. The question is how the translocated PC is extracted
from the canalicular membrane. In the past we favored a vesic-
ulation model, which involves vesiculation of the exoplasmic
leaﬂet induced by PC translocation combined with bile salt
micelle-induced destabilization [111]. Alternatively, bile salt
micelles may extract the PC directly from ABCB4. The latter
model suggests that ABCB4, apart from being a ﬂoppase,
has a ‘‘liftase’’ activity as was proposed for the cholesterol
transporter ABCG5/G8 heterodimer (see below) [112].2.3. The ABCD subfamily
The ABCD subfamily contains 4 half transporters which are
speciﬁcally expressed in the peroxisome.
2.3.1. ABCD1 – X-linked adrenoleukodystrophy. X-linked
adrenoleukodystrophy (X-ALD) is a neurodegenerative disor-
der characterized by plasma and tissue accumulation of very
long-chain fatty acids (VLCFA) [113]. Many X-ALD patients
present with central demyelination and peripheral axonopathy
[114]. ABCD1 is implicated in the peroxisomal import of
VLCFA, substrates in the peroxisomal b-oxidation [115].
However, the exact mechanisms involved are poorly under-
stood. Abcd1/ mice display both VLCFA accumulation
and neurodegenerative features which are rescued when Abcd2
is transgenically expressed [116]. Abcd1//Abcd2/ display a
more severe neurological phenotype than the single knockouts
[116]. In addition, VLCFA b-oxidation was restored when
ABCD2 was overexpressed in X-ALD ﬁbroblasts [117]. These
observations suggest both a redundant function and a role for
these proteins in parallel pathways. In vitro, both homo- and
heterodimerization has been demonstrated for ABCD1,
ABCD2, and, ABCD3 [118]. Whether these proteins function
as homo- and/or heterodimers in vivo remains to be deter-
mined.2.4. The ABCG subfamily
The human ABCG subfamily contains 5 half transporters,
i.e. ABCG1, 2, 4, 5, and 8. ABCG2 is a transporter for xeno-
biotics [119]. ABCG1 and ABCG4 have been implicated in
lipid eﬄux (predominantly cholesterol and sphingomyelin)
from peripheral cells to HDL [120,121]. ABCG5 and ABCG8
form a heterodimer that mediates the translocation of plant
sterols, but also cholesterol.
2.4.1. ABCG5/G8 – sitosterolemia. Sitosterolemia is a rare
autosomal recessive disorder caused by mutations in either
ABCG5 or ABCG8 [122]. Patients are characterized by ele-
vated plasma sterol levels due to intestinal hyperabsorbtion
of plant sterols and cholesterol, and impaired hepatobiliary
sterol excretion [123]. ABCG5 and ABCG8 exist as a heterodi-mer that is exclusively expressed in the apical membrane of
enterocytes and hepatocytes [124]. Abcg5//g8/ mice dis-
played strongly reduced biliary cholesterol excretion and en-
hanced intestinal absorption of plant sterols [125]. hG5G8Tg
transgenic mice which express about 14 copies of human
ABCG5/G8 displayed a 6-fold increase in biliary cholesterol
output compared to control [126]. These data indicate that this
heterodimer mediates the translocation of cholesterol and
plant sterols. As for ABCB4, the question arises how choles-
terol ends up in bile. Small [112] argued that cholesterol possi-
bly does not require a transporter to partition between the two
leaﬂets, unless the canalicular membrane is a solid, raft-like
structure. Indeed, spontaneous ﬂip-ﬂop of cholesterol in artiﬁ-
cial membranes has been reported to be fast [127]. Thus,
ABCG5/G8 may function as a liftase, an activity that pushes
the substrate out of the bilayer making it available for extrac-
tion by mixed micelles.3. Disorders caused by type 4 P-type ATPase deﬁciencies
3.1. ATP8B1 – progressive familial intrahepatic cholestasis
type 1 (PFIC1)
ATP8B1 deﬁciency causes a severe autosomal recessive
liver disorder, PFIC1, or a less severe form termed benign
recurrent intrahepatic cholestasis type 1 (BRIC1)
[98,128,129]. Both disorders are characterized by impaired
bile salt excretion (i.e. cholestasis) from liver into bile. PFIC1
primarily manifests as a chronic intrahepatic cholestasis
which progresses to severe, end-stage liver disease and often
requires orthotopic liver transplantation during the ﬁrst or
second decade of life. In BRIC1, the cholestatic periods are
recurrent and resolve spontaneously without leaving detect-
able liver damage. An inventory of mutations in ATP8B1
has been described which relates the type and location of
the mutation to the clinical manifestation of PFIC1/BRIC1
[130]. ATP8B1 is expressed in the apical membrane of many
epithelial cells, including the canalicular membrane of hepa-
tocytes. We have recently shown in a mouse model for
PFIC1, Atp8b1G308V/G308V mutant mice, that Atp8b1 deﬁ-
ciency dissipates transbilayer phospholipid distribution,
which renders the canalicular membrane more sensitive to
detergent bile salts [131]. Upon infusion of taurocholate,
Atp8b1 mutants, but not wild-type mice, displayed a 2-fold
increase in biliary output of cholesterol. In addition,
Atp8b1-mutants had signiﬁcant amounts of PS in their bile.
The Atp8b1-deﬁcient phenotype coincided with impaired
transport of hydrophobic bile salts from liver into bile. We
hypothesize that phospholipid randomization and subsequent
enhanced extraction of cholesterol by hydrophobic bile salts,
impairs the activity of ABCB11 and causes cholestasis. In vi-
tro studies have shown that ATP8B1 overexpression resulted
in enhanced uptake of NBD-PS in a mutant CHO cell line
[132]. Recent experiments from our lab indicate that
ATP8B1-mediated NBD-PS translocation in these same
CHO cells requires co-expression of, and complexing with a
possible b-subunit of this P-type ATPase, CDC50B (Paul-
usma et al., submitted for publication) [36,37]. Collectively,
these data implicate a role for ATP8B1 as a canalicular lipid
ﬂippase that translocates PS from the exoplasmic to the cyto-
plasmic leaﬂet of the bilayer. Whether other lipid species are
translocated remains to be determined.
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human disease caused by defects in intramembranous trans-
port of lipids. Murine Atp8b3 has been implicated in sperm
capacitation, and may underlie fertility-related disorders
[133]. Type 4 ATPase-deﬁciencies may also cause more general
defects in lipid metabolism. For instance, murine Atp10a, has
been implicated in obesity, type 2 diabetes, and non-alcoholic
fatty liver disease [134]. Similarly, Atp10d, which belongs to
the same class as Atp10a, has been implicated in lipid metabo-
lism [135]: of 15 inbred mouse strains only the C57BL/6J strain
contained a premature stop codon in Atp10d, resulting in a
non-functional protein; interestingly, C57BL/6J mice are pre-
disposed to develop obesity, hyperglycemia, hyperinsulinemia,
and hypertension when fed a high-fat diet [136].4. Disorders caused by scramblase deﬁciencies
4.1. Scott syndrome
Scott syndrome is an autosomal recessive bleeding disorder
in which blood platelets, erythrocytes, and lymphocytes have
a defect in Ca2+-induced PS exposure with otherwise normal
amounts of membrane phospholipids and lipid ﬂippase activity
[137]. This defect results in impaired assembly and activation of
two membrane-associated enzyme complexes that are indis-
pensable for normal blood clotting [138]. Scott syndrome lym-
phocytes are insensitive to Ca2+-induced PS exposure, while
apoptotic lymphocytes from these patients do expose PS [26].
This suggests the presence of at least two distinct scramblase
activities, a Ca2+-inducable one and a scramblase activated
during apoptosis. Which proteins are involved in Scott syn-
drome remains to be determined. PLSCR1 is normally ex-
pressed in Scott syndrome lymphocytes, and no mutations in
the gene could be detected which renders a role in Scott syn-
drome unlikely [139]. The contribution of PLSCR1 homologs
is presently not known. A second candidate protein is ABCA1,
which is also expressed in blood platelets. As described above,
ABCA1 is thought to translocate PS. Indeed, platelet activation
is impaired in both TD patients and Abca1/ mice, but this is
not accompanied by a change in PS exposure [140]. Recently, a
role for ABCA1 in one Scott syndrome patient with an ABCA1
traﬃcking defect was reported [141]; complementation of
lymphocytes of this patient with ABCA1 restored Ca2+-in-
duced PS exposure in these cells, a process that was completely
blocked by the ABCA1 inhibitor glyburide. These data may
suggest that impaired ABCA1 function contributes to the phe-
notype of Scott syndrome but this remains to be determined by
studying a larger group of patients. The primary defect in Scott
syndrome remains unsolved.5. Concluding remarks
The severity of inherited diseases associated with intramem-
brane lipid transport underscores the physiological relevance
of these activities. ABC transporters are clearly important in
maintaining lipid homeostasis. ABC transporters mediate the
translocation of lipids from the cytoplasmic- to the exoplas-
mic/luminal leaﬂet of the bilayer. These translocated lipids
are employed either in the biogenesis of lipid-containing vesi-
cles, or for neutralizing compounds that are toxic to cells. Type
4 ATPases, being putative lipid ﬂippases, mediate the translo-cation of lipids from the exoplasmic- to the cytosolic leaﬂet. At
this moment it remains to be elucidated how type 4 ATPases
and phospholipid scramblases interplay in the regulation of
cellular homeostasis and how impairment of these activities re-
lates to human disease. Although there is consensus on the
physiological function for some of the proteins discussed in
this paper, the molecular mechanisms by which these proteins
act are still poorly understood. This is mainly due to the diﬃ-
culties that arise when developing reliable assays to study
intramembranous transport. In order to unravel the molecular
mechanisms of lipid transport, the combination of in vivo,
biochemical, and structural analyses for intramembrane
transporters is indispensable.
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